Integrated Clinical Trial Services Introduces New Service
ICTS To Provide Study Information Websites
Raleigh, NC – Tom Sturgis, President of Integrated Clinical Trial Services (ICTS) announced that the firm has introduced a new service to provide Study Information Websites as part of a comprehensive patient services program. The Study Information Websites are third party verifiable information resources for individual clinical trials, permitting patients to look up specific information about the trial they are participating in and serving as a backup for other information sources. The Study Information Websites are web-optimized, and appear credible in the top 10 results of any search engine, resulting in additional patient recruitment as individuals search the web for information on their condition.
"We are pleased to be able to offer this new service as part of our comprehensive plan," said Sturgis. "It is important that patients have correct and valid information about their condition and can learn about opportunities to participate in clinical trials. We are excited to provide them with an additional source of knowledge."
About Integrated Clinical Trial Services:
Integrated Clinical Trial Services is a full service patient enrollment firm that provides clinical trial sponsors, contract research organizations and site networks with a comprehensive resource for patient recruitment expertise. The firm's services include patient enrollment feasibility, recruitment strategy, consulting, market research and protocol review, project management, concept design and production, media placement, community resource support, compliance and retention, and more. For more information please call (919) 388-3964. Integrated Clinical Trial Services can be found on the Internet at http://www.integratedtrials.com.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
FDA Grants Ziftomenib with Breakthrough Therapy Designation for NPM1-Mutant Acute Myeloid Leukemia
April 23rd 2024Data from the Phase Ib portion of the KOMET-001 trial showed that the once-daily oral treatment may provide a substantial improvement over available therapies for relapsed/refractory NPM1-mutant acute myeloid leukemia.
